SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : wla(warner lambert) -- Ignore unavailable to you. Want to Upgrade?


To: Captain Jack who wrote (647)3/29/1999 1:20:00 PM
From: Anthony Wong  Read Replies (1) | Respond to of 942
 
Analysts ratings issued today:

Bear Stearns reiterates buy, FDA panel votes to keep Rezulin on market for combination use only

Brown Brothers reiterates strong buy ST, buy LT

CIBC/Oppenheimer reiterates buy, target $80, expect stock to be strong after favorable FDA meeting

Everen Securities ret 1-1 rating, Rezulin will be kept on the market, short term target $88, long term $94

Gruntal & Co. reiterates hold, after FDA meeting

Paine Webber reiterates buy, FDA review last Friday